Metastatic pancreatic neuroendocrine tumors (pNET): placing current findings into perspective.
about
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancerHealth-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learnedThe use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances
P2860
Metastatic pancreatic neuroendocrine tumors (pNET): placing current findings into perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metastatic pancreatic neuroend ...... ent findings into perspective.
@en
Metastatic pancreatic neuroendocrine tumors
@nl
type
label
Metastatic pancreatic neuroend ...... ent findings into perspective.
@en
Metastatic pancreatic neuroendocrine tumors
@nl
prefLabel
Metastatic pancreatic neuroend ...... ent findings into perspective.
@en
Metastatic pancreatic neuroendocrine tumors
@nl
P1476
Metastatic pancreatic neuroend ...... ent findings into perspective.
@en
P2093
Alexandria T Phan
P356
10.1016/J.CTRV.2012.02.010
P577
2012-03-27T00:00:00Z